$COSM News

Cosmos Health Provides Balance Sheet Update; Notes No Known Business Reason For Recent Share Price Decline

Cosmos Health Expands C-Scrub Into Veterinary Market Following EU Antimicrobial Testing

CORRECTION: Cosmos Health Expects To Report Over $90M In FY26; Anticipates Adjusted EPS Of $0.73, $200.6M In Revenue By 2029

Cosmos Health Expects FY29 Adjusted EPS Of $0.73, Revenue Of $200.6M

Cosmos Health Q1 EPS $(0.06) Misses $(0.01) Estimate, Sales $17.928M Miss $21.893M Estimate

Cosmos Health Expects Fort18 To Report More Than $3.2M Incremental Annual U.S. Revenue Over Next 12 To 18 Months

Cosmos Health Projects Cur18 Supplement To Generate $2.5M+ Annual Revenue Within 18-Months

Cosmos Health Says Liv18 Liver Supplement Completes Phase 1 Ahead Of Schedule; U.S. Production Begins April 2026 With $5M+ Projected Annual Revenue

Cosmos Health Expands AI Integration Across Operations And R&D To Boost Efficiency And Growth

Cosmos Health shares are trading higher after the company reported better-than-expected Q4 financial results.

Cosmos Health shares are trading higher after the company reported better-than-expected Q4 financial results.

Cosmos Health Q4 Adj. EPS $(0.04), Inline, Sales $19.703M Beat $18.821M Estimate

Cosmos Health Secures Third UAE Purchase Order For 60K Units Of Its Sky Premium Life, Bringing Cumulative Orders To 270K Units Since June 2024

Cosmos Health Confirms Ongoing Conflict In Iran And Broader Mideast Geopolitical Tensions Haven't Had Material Impact On Its Operations; Says US Expansion, Including Rollout Of NOOR Collagen, Remains On Track

Cosmos Health Announces Planned Launch of Liv18 Liver Health Supplement In Q2 2026

Cosmos Health Announces Testing Completion Of C-Scrub Wash 4% Under European Standard For Surgical Hand Disinfection Shows Effective Antimicrobial Activity

Cosmos Health Reports Revenue And Operating Metrics; Projects $12M Annualized U.S. NOOR Collagen Sales With 75% Gross Margins, Pursues U.S. Expansion And M&A Pipeline Including $11.5M Pharmacy Network Acquisition; Holds $18M In Non-Core Assets To Support Strategic Investments; Says Maintains Strong Growth Despite Geopolitical Turmoil; Plans To Issue Updated 2025 Operational, Strategic, And Financial Guidance Following Q4, FY25 Results

Cosmos Health Reports Record Revenue And Operating Metrics; Projects $12M Annualized U.S. NOOR Collagen Sales With 75% Gross Margins, Pursues U.S. Expansion And M&A Pipeline Including $11.5M Pharmacy Network Acquisition; Holds $18M In Non-Core Assets To Support Strategic Investments; Says Maintains Strong Growth Despite Geopolitical Turmoil; Plans To Issue Updated 2025 Operational, Strategic, And Financial Guidance Following Q4, FY25 Results

Cosmos Health Announces Purchase Of $600,000 Of Bitcoin As Part Of Its Ongoing Digital Assets Treasury Initiative

Cosmos Health Enters Into LOI To Acquire Extensive Pharmacy Distribution Network, Terms Not Disclosed; Remains On Track To Deliver 2027 Revenue Guidance Of $155.8M